These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22491688)

  • 1. Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistance.
    Frey KM; Viswanathan K; Wright DL; Anderson AC
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3556-62. PubMed ID: 22491688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase.
    Frey KM; Lombardo MN; Wright DL; Anderson AC
    J Struct Biol; 2010 Apr; 170(1):93-7. PubMed ID: 20026215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance.
    Frey KM; Liu J; Lombardo MN; Bolstad DB; Wright DL; Anderson AC
    J Mol Biol; 2009 Apr; 387(5):1298-308. PubMed ID: 19249312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant
    Reeve SM; Si D; Krucinska J; Yan Y; Viswanathan K; Wang S; Holt GT; Frenkel MS; Ojewole AA; Estrada A; Agabiti SS; Alverson JB; Gibson ND; Priestley ND; Wiemer AJ; Donald BR; Wright DL
    ACS Infect Dis; 2019 Nov; 5(11):1896-1906. PubMed ID: 31565920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonracemic Antifolates Stereoselectively Recruit Alternate Cofactors and Overcome Resistance in S. aureus.
    Keshipeddy S; Reeve SM; Anderson AC; Wright DL
    J Am Chem Soc; 2015 Jul; 137(28):8983-90. PubMed ID: 26098608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charged Propargyl-Linked Antifolates Reveal Mechanisms of Antifolate Resistance and Inhibit Trimethoprim-Resistant MRSA Strains Possessing Clinically Relevant Mutations.
    Reeve SM; Scocchera E; Ferreira JJ; G-Dayanandan N; Keshipeddy S; Wright DL; Anderson AC
    J Med Chem; 2016 Jul; 59(13):6493-500. PubMed ID: 27308944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity.
    Lamb KM; Lombardo MN; Alverson J; Priestley ND; Wright DL; Anderson AC
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7484-91. PubMed ID: 25288083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureus.
    Wang S; Reeve SM; Holt GT; Ojewole AA; Frenkel MS; Gainza P; Keshipeddy S; Fowler VG; Wright DL; Donald BR
    PLoS Comput Biol; 2022 Feb; 18(2):e1009855. PubMed ID: 35143481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-specific 1H, 13C and 15N assignment of the TMP-resistant dihydrofolate reductase mutant DHFR(F98Y) in the ternary complex with TMP and NADPH.
    Altmann S; Labhardt AM; Senn H; Wüthrich K
    J Biomol NMR; 1997 Jun; 9(4):445-6. PubMed ID: 9255948
    [No Abstract]   [Full Text] [Related]  

  • 10. Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates.
    Lombardo MN; G-Dayanandan N; Wright DL; Anderson AC
    ACS Infect Dis; 2016 Feb; 2(2):149-56. PubMed ID: 27624966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to antibacterial antifolates in multidrug-resistant Staphylococcus aureus: prevalence estimates and genetic basis.
    Kime L; Waring T; Mohamad M; Mann BF; O'Neill AJ
    J Antimicrob Chemother; 2023 May; 78(5):1201-1210. PubMed ID: 36935372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
    Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trimethoprim derivative impedes antibiotic resistance evolution.
    Manna MS; Tamer YT; Gaszek I; Poulides N; Ahmed A; Wang X; Toprak FCR; Woodard DR; Koh AY; Williams NS; Borek D; Atilgan AR; Hulleman JD; Atilgan C; Tambar U; Toprak E
    Nat Commun; 2021 May; 12(1):2949. PubMed ID: 34011959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus.
    Oefner C; Parisi S; Schulz H; Lociuro S; Dale GE
    Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):751-7. PubMed ID: 19622858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Resistance to Folate Pathway Inhibitors in
    Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
    Oefner C; Bandera M; Haldimann A; Laue H; Schulz H; Mukhija S; Parisi S; Weiss L; Lociuro S; Dale GE
    J Antimicrob Chemother; 2009 Apr; 63(4):687-98. PubMed ID: 19211577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454).
    Sekiguchi J; Tharavichitkul P; Miyoshi-Akiyama T; Chupia V; Fujino T; Araake M; Irie A; Morita K; Kuratsuji T; Kirikae T
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3948-51. PubMed ID: 16127079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
    Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
    Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria.
    Schneider P; Hawser S; Islam K
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4217-21. PubMed ID: 14623005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-guided functional studies of plasmid-encoded dihydrofolate reductases reveal a common mechanism of trimethoprim resistance in Gram-negative pathogens.
    Krucinska J; Lombardo MN; Erlandsen H; Estrada A; Si D; Viswanathan K; Wright DL
    Commun Biol; 2022 May; 5(1):459. PubMed ID: 35562546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.